Post Marketing Active Surveillance to Evaluate the Safety and Efficacy of Aprepitant (EMEND®) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) Associated with High Emetogenic Cancer Chemotherapy in China (MK-0869-804) | HMA-EMA Catalogues of real-world data sources and studies